# Lantheus Medical Imaging, Inc., North Billerica, MA – FDA Inspections

Source: https://www.keypedia.com/companies/lantheus-medical-imaging-inc/6e9954f9-4df0-41b8-bad7-e8117a91ef76

> Inspection records and compliance data for Lantheus Medical Imaging, Inc. in North Billerica, Massachusetts. 8 FDA inspections on record, 1 Form 483, last inspected April 09, 2026.

---

## Details

- Name: Lantheus Medical Imaging, Inc.
- FEI Number: 1216602
- Address Line 1: 331 Treble Cove Rd
- City: North Billerica
- State: Massachusetts
- Zip Code: 01862
- Country Name: United States
- Address: 331 Treble Cove Rd, North Billerica, Massachusetts 01862, United States
- Country: United States

## Related Documents

- [483 - Lantheus Medical Imaging, Inc. - 2026-04-09](https://www.keypedia.com/records/483/lantheus-medical-imaging-inc/16ac8a8e-d900-4971-8a0b-df55a8e30070) — source: FDA, date: April 9, 2026
- [FDA Inspection 1312058 - Lantheus Medical Imaging, Inc. - 2026-04-09](https://www.keypedia.com/records/fda_inspections/lantheus-medical-imaging-inc/1dcaf4cb-48f6-4808-a1ff-cfe624cc3ecc) — source: FDA, date: April 9, 2026
- FDA Inspection 1230687 - Lantheus Medical Imaging, Inc. - 2023-12-21 — classification: No Action Indicated (NAI), source: FDA, date: December 21, 2023
- FDA Inspection 1040729 - Lantheus Medical Imaging, Inc. - 2018-01-19 — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2018
- FDA Inspection 925847 - Lantheus Medical Imaging, Inc. - 2015-03-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 5, 2015
- FDA Inspection 925847 - Lantheus Medical Imaging, Inc. - 2015-03-05 — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2015
- [FDA Inspection 837087 - Lantheus Medical Imaging, Inc. - 2013-06-20](https://www.keypedia.com/records/fda_inspections/lantheus-medical-imaging-inc/c15bf4d8-a17d-4e26-abd4-8393247725da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2013
- [FDA Inspection 733748 - Lantheus Medical Imaging, Inc. - 2011-07-18](https://www.keypedia.com/records/fda_inspections/lantheus-medical-imaging-inc/2b0bee10-4d73-4b60-987d-4daee0428559) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2011
- FDA Inspection 597594 - Lantheus Medical Imaging, Inc. - 2009-07-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2009
- FDA Inspection 603232 - Lantheus Medical Imaging, Inc. - 2009-07-01 — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2009

## Related Companies

- [IBSA Institut Biochimique SA](https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e)
- [Merck Serono S.p.A.](https://www.keypedia.com/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [Patheon Inc.](https://www.keypedia.com/companies/patheon-inc/76561a83-edb8-4c76-934b-6b2bd5e67949)
- [Anesta LLC](https://www.keypedia.com/companies/anesta-llc/821f19a7-cabd-47ab-a635-7880a3c5046d)
- [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)
- [Bora Pharmaceuticals Laboratories, Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-laboratories-inc/9bb86ed9-7d7d-4886-a145-b9497462c295)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [AstraZeneca Nijmegen B.V.](https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)

## Related Officers

- [M.S., Consumer Safety Officer at FDA](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Deputy Director](https://www.keypedia.com/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)
